Antifungal susceptibility testing: practical aspects and current challenges

J. H. Rex, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, Frank Christopher Odds, M. G. Rinaldi, D. J. Sheehan, D. W. Warnock, M. A. Pfaller

    Research output: Contribution to journalArticle

    346 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)643-58
    Number of pages16
    JournalClinical Microbiology Reviews
    Volume14
    Issue number4
    DOIs
    Publication statusPublished - 2001

    Keywords

    • IN-VITRO SUSCEPTIBILITY
    • AMPHOTERICIN-B SUSCEPTIBILITY
    • BROTH MICRODILUTION METHODS
    • FLUCONAZOLE-RESISTANT CANDIDA
    • LABORATORY STANDARDS METHOD
    • MEDIATED GROWTH-INHIBITION
    • VIRUS-INFECTED PATIENTS
    • TIME-KILL METHODS
    • CRYPTOCOCCUS-NEOFORMANS
    • ASPERGILLUS-FUMIGATUS

    Cite this

    Rex, J. H., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., ... Pfaller, M. A. (2001). Antifungal susceptibility testing: practical aspects and current challenges. Clinical Microbiology Reviews, 14(4), 643-58. https://doi.org/10.1128/CMR.14.4.643-658.2001

    Antifungal susceptibility testing: practical aspects and current challenges. / Rex, J. H.; Walsh, T. J.; Chaturvedi, V.; Espinel-Ingroff, A.; Ghannoum, M. A.; Gosey, L. L.; Odds, Frank Christopher; Rinaldi, M. G.; Sheehan, D. J.; Warnock, D. W.; Pfaller, M. A.

    In: Clinical Microbiology Reviews, Vol. 14, No. 4, 2001, p. 643-58.

    Research output: Contribution to journalArticle

    Rex, JH, Walsh, TJ, Chaturvedi, V, Espinel-Ingroff, A, Ghannoum, MA, Gosey, LL, Odds, FC, Rinaldi, MG, Sheehan, DJ, Warnock, DW & Pfaller, MA 2001, 'Antifungal susceptibility testing: practical aspects and current challenges', Clinical Microbiology Reviews, vol. 14, no. 4, pp. 643-58. https://doi.org/10.1128/CMR.14.4.643-658.2001
    Rex JH, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, Gosey LL et al. Antifungal susceptibility testing: practical aspects and current challenges. Clinical Microbiology Reviews. 2001;14(4):643-58. https://doi.org/10.1128/CMR.14.4.643-658.2001
    Rex, J. H. ; Walsh, T. J. ; Chaturvedi, V. ; Espinel-Ingroff, A. ; Ghannoum, M. A. ; Gosey, L. L. ; Odds, Frank Christopher ; Rinaldi, M. G. ; Sheehan, D. J. ; Warnock, D. W. ; Pfaller, M. A. / Antifungal susceptibility testing: practical aspects and current challenges. In: Clinical Microbiology Reviews. 2001 ; Vol. 14, No. 4. pp. 643-58.
    @article{b736551855c54ff5b6adc395db2f10f8,
    title = "Antifungal susceptibility testing: practical aspects and current challenges",
    keywords = "IN-VITRO SUSCEPTIBILITY, AMPHOTERICIN-B SUSCEPTIBILITY, BROTH MICRODILUTION METHODS, FLUCONAZOLE-RESISTANT CANDIDA, LABORATORY STANDARDS METHOD, MEDIATED GROWTH-INHIBITION, VIRUS-INFECTED PATIENTS, TIME-KILL METHODS, CRYPTOCOCCUS-NEOFORMANS, ASPERGILLUS-FUMIGATUS",
    author = "Rex, {J. H.} and Walsh, {T. J.} and V. Chaturvedi and A. Espinel-Ingroff and Ghannoum, {M. A.} and Gosey, {L. L.} and Odds, {Frank Christopher} and Rinaldi, {M. G.} and Sheehan, {D. J.} and Warnock, {D. W.} and Pfaller, {M. A.}",
    year = "2001",
    doi = "10.1128/CMR.14.4.643-658.2001",
    language = "English",
    volume = "14",
    pages = "643--58",
    journal = "Clinical Microbiology Reviews",
    issn = "0893-8512",
    publisher = "American Society for Microbiology",
    number = "4",

    }

    TY - JOUR

    T1 - Antifungal susceptibility testing: practical aspects and current challenges

    AU - Rex, J. H.

    AU - Walsh, T. J.

    AU - Chaturvedi, V.

    AU - Espinel-Ingroff, A.

    AU - Ghannoum, M. A.

    AU - Gosey, L. L.

    AU - Odds, Frank Christopher

    AU - Rinaldi, M. G.

    AU - Sheehan, D. J.

    AU - Warnock, D. W.

    AU - Pfaller, M. A.

    PY - 2001

    Y1 - 2001

    KW - IN-VITRO SUSCEPTIBILITY

    KW - AMPHOTERICIN-B SUSCEPTIBILITY

    KW - BROTH MICRODILUTION METHODS

    KW - FLUCONAZOLE-RESISTANT CANDIDA

    KW - LABORATORY STANDARDS METHOD

    KW - MEDIATED GROWTH-INHIBITION

    KW - VIRUS-INFECTED PATIENTS

    KW - TIME-KILL METHODS

    KW - CRYPTOCOCCUS-NEOFORMANS

    KW - ASPERGILLUS-FUMIGATUS

    U2 - 10.1128/CMR.14.4.643-658.2001

    DO - 10.1128/CMR.14.4.643-658.2001

    M3 - Article

    VL - 14

    SP - 643

    EP - 658

    JO - Clinical Microbiology Reviews

    JF - Clinical Microbiology Reviews

    SN - 0893-8512

    IS - 4

    ER -